Commercial Excellence Resources

Digital health has grown and evolved rapidly in the past decade—spurred by exciting developments in AI, machine learning, and the internet of things (IoT), alongside nearly ubiquitous adoption of smar

The innovation and business acceleration group of an F200 pharmaceutical company was preparing to launch a new cardiovascular device with an accompanying digital therapeutic product. Looking for a...

An EMEA-based leading construction materials company was seeking to conduct application studies to identify expanded use cases and commercial potential for existing product offerings to develop a...

Independent talent provide an agile source of critical skills that allow life science leaders to keep pace in a fast-changing environment.

A multinational Fortune Global 500 pharma and life sciences company sought to develop a strategic approach to healthcare provider (HCP) engagement across its consumer health portfolio. Following a...

The director of ophthalmology marketing at a F500 biopharma was under-resourced heading into two critical product launches. Under a tight launch timeline, he needed a consultant who could quickly...

The medical specialties insights and analytics team of a multinational pharmaceutical company was understaffed with open headcount and two employees leaving for parental leave. The team needed a...

Succeeding in today’s commercial environment requires agility and rapid response to new market conditions and quickly evolving consumer attitudes and behaviors. Here's how independent talent can help.

When the COVID pandemic hit, the marketing team at an F150 biopharma company shifted its speaker and educational programs to a virtual format. However, the team then recognized that the content...

How can pharma marketers remain effective and relevant for key customers, patients, and healthcare providers (HCPs) in the time of COVID-19?

On-demand talent is a critical resource for life science and pharma companies as they innovate to keep pace with market changes, respond to emerging health threats, and adapt to a remote environment.

In an effort to inform its Rare Diseases commercial strategy within a specific country, an F100 pharmaceutical company was looking to gain a deeper understanding of the current competitive...

As companies shift focus from triaging operations to long-term strategy, here are the top trends and opportunities to watch in the pandemic recovery phase.

An F200 pharma company wanted to implement next generation digital health technologies, which required a thorough review of the existing strategy across three therapeutic areas and a roadmap for...

Commercial strategy leaders must prepare now to ensure success for potential COVID-19 treatments. Biopharma expert Marc Cooley shares what life science companies should keep in mind at this moment.

COVID-19 is sidelining the field reps that life science companies rely on for in-person pharmaceutical detailing. Healthcare marketing strategist Martine Taylor discusses how eDetailing can help.

Independent biopharma marketer Kimberly Crichton explains how technology is changing the way life science companies launch products and communicate with consumers and healthcare providers.